mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch

PLoS One. 2012;7(10):e37807. doi: 10.1371/journal.pone.0037807. Epub 2012 Oct 24.

Abstract

Anaplastic thyroid carcinoma (ATC) is the most lethal form of thyroid neoplasia and represents the end stage of thyroid tumor progression. No effective treatment exists so far. ATC frequently derive from papillary thyroid carcinomas (PTC), which have a good prognosis. In this study, we analyzed the mRNA expression profiles of 59 thyroid tumors (11 ATC and 48 PTC) by microarrays. ATC and PTC showed largely overlapping mRNA expression profiles with most genes regulated in all ATC being also regulated in several PTC. 43% of the probes regulated in all the PTC are similarly regulated in all ATC. Many genes modulations observed in PTC are amplified in ATC. This illustrates the fact that ATC mostly derived from PTC. A molecular signature of aggressiveness composed of 9 genes clearly separates the two tumors. Moreover, this study demonstrates gene regulations corresponding to the ATC or PTC phenotypes like inflammatory reaction, epithelial to mesenchymal transition (EMT) and invasion, high proliferation rate, dedifferentiation, calcification and fibrosis processes, high glucose metabolism and glycolysis, lactate generation and chemoresistance. The main qualitative differences between the two tumor types bear on the much stronger EMT, dedifferentiation and glycolytic phenotypes showed by the ATC.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Carcinoma / blood supply
  • Carcinoma / genetics*
  • Carcinoma / pathology
  • Carcinoma, Papillary
  • Cell Proliferation
  • Gene Expression Profiling
  • Humans
  • Neovascularization, Pathologic
  • Nucleic Acid Hybridization
  • Oligonucleotide Array Sequence Analysis
  • RNA, Messenger / genetics*
  • Real-Time Polymerase Chain Reaction
  • Thyroid Cancer, Papillary
  • Thyroid Carcinoma, Anaplastic
  • Thyroid Neoplasms / blood supply
  • Thyroid Neoplasms / genetics*
  • Thyroid Neoplasms / pathology

Substances

  • RNA, Messenger

Grants and funding

This work was supported by Welbio, Télévie, European Union (GENRISK-T project 036495), Fonds de la Recherche Scientifique Médicale, Fondation Van Buren, Les amis de l’Institut Bordet, Fondation Contre le Cancer, Fonds National de la Recherche Scientifique (FNRS). ATC tissue samples from Lille were obtained from from the tumour cell and tissue bank of Regional Reference Cancer Center of Lille “Tumorothèque du centre régional de Référence en Cancérologie”(France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.